Charles River Laboratories International (CRL) Capital Expenditures (2009 - 2025)

Charles River Laboratories International's Capital Expenditures history runs 17 years deep, the most recent figure standing at $89.0 million for Q4 2025.

• In Q4 2025, Capital Expenditures rose 17.63% year-over-year to $89.0 million; the TTM figure through Dec 2025 stood at $219.2 million (down 5.93% YoY), while the FY2025 annual figure was $219.2 million, down 5.93% from the prior year.
• Capital Expenditures was $89.0 million for Q4 2025 at Charles River Laboratories International, up from $35.6 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $106.9 million in Q2 2023 to a low of $28.0 million in Q1 2021.
• Historically, Capital Expenditures has averaged $66.2 million across 5 years, with a median of $69.9 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 187.06% in 2022, then slumped 41.4% in 2024.
• A 5-year view of Capital Expenditures shows it stood at $98.8 million in 2021, then declined by 9.87% to $89.0 million in 2022, then retreated by 12.02% to $78.3 million in 2023, then dropped by 3.46% to $75.6 million in 2024, then grew by 17.63% to $89.0 million in 2025.
• The last three Capital Expenditures figures came in at $89.0 million (Q4 2025), $35.6 million (Q3 2025), and $35.3 million (Q2 2025), per Business Quant data.